Subject: THE LIVERPOOL EXPERIMENT IN DANGER
X-Listprocessor-Version: 6.0 -- ListProcessor by Anastasios Kotsikonas
X-Comment: The Transnational Radical Party List
PETITION FOR DR. JOHN MARKS
On 1st April 1995, Doctor John Marks will cease to be in charge of the drug
dependence clinics at Widnes and Warrington. The local public health
authorities have chosen to call a halt to what has been called "The
Liverpool Experiment", the controlled distribution of hard drugs among
addicts in the Mersey region. Over the last 12 years John Marks'initiative
has produced a number of social and public health results, including a
dramatic reduction of criminality and illegal drugs peddling, an
extraordinary low rate of H.I.V. infection among the addicts treated at the
Widness and Warrington clinics, and, most surprising of all, a dramatic
reduction in the incidence of addiction.
Given the general implications of harm reduction for worldwide public
health policy, we, specialists from all over the globe, solemnly declare
that it is most important that Doctor Marks should continue witt his
practice, as he has done successfully for the last 12 years.
(Name) (Surname) (Address)
(Radical Party - CoRA, Via di Torre Argentina 76, 00186 Rome, Italy, tel.
39-6-689.791, fax. 39-6-6880.5396, E-mail Radical.Party@agora.stm.it)
(Editions du Le'zard, 9, Passage Dagorno, 75020 Paris, tel.
33-1-40.09.69.69, fax. 33-1-40.09.69.71)
FIRST SIGNATURES ON THE "MARKS APPEAL"
Nick HARMAN, journalist, United Kingdom; Antonio ESCOHOTADO, Author,
Madrid, Spain; Dr. Bertrand LEBEAU, Me'decins du Monde, Paris, France;
Jean-Pierre GALLAND, auteur et pre'sident du C.I.R.C., Paris, France;
Francis CABALLERO, avocat, pre'sident du M.L.C., Paris, France; MICHKA,
journaliste et auteur, Paris, France; Philip L. GILLIAM, UAW Unemployement
Clinic, Detroit, USA; David C. CONDLIFE, The Drug Policy Foundation,
Whashington DC, USA; Anthony HENMAN, Director, Drug Reform, United Kingdom;
Ethan NADELMANN, Lindtsmith Center, NYC, USA; Laura GREER, University of
Kansas, Kansas, USA; Dr Christa APPEL, Forschungsgruppe, Frankfurt am Main,
Germany; Joey TRANCHINA, Executive Director, Aids Prevention Action Network
Inc., USA; David PURCHUM, PDAP, Tacoma, Washington, USA; Henk Jan VAN
VLIET, consultancy Resaerch, Amsterdam, Netherlands; Dan WEILLER, The
Lindesmith Center, New York, USA; Mario LAP, NIAD, Netherlands; Dale
GLERINGER, Phl D., Bekerley, USA; Craig REINARMAN, Sociology Dept, Univ. of
California, USA; Ed ROSENTHAL, Cannabis Legal Research Association, San
Francisco, USA; Prof. Dr. Lorenz BLLINGER, University of Bremen, Germany;
Ron OWENS, Executive Director Australian Drug law reform foundation,
Canberra, Australia; Warren D. SAMET, Director of Program Management,
Spectrum Programs, inc. Miami, USA; Arnold S. TREBACH, Phi. D., president
of Drug Policy Foundation, Washington DC, USA; Dennis PERON, Californians
for Compassionate Use, San Francisco, USA; Eric FROMBERG, NIAD,
Netherlands; Alan CLEAR, Executive Director, Lower East Side Harm Reduction
Center, NYC, USA; David F. DUNCAN, Research Associate Professor, Brown
University Medical School, USA; Howard S. LOTSOF, president NDA
International, New York, USA; Jean-Rene' DARD, pre'sident de l'A.S.U.D.,
Paris, France; Emmanuel MORGAN, secre'taire ge'ne'ral de l'A.S.U.D.,
France; Dominique VOYNET, porte parole du groupe "Les Verts", Paris France;
Thierry MEYSSAN, pre'sident du Re'seau Voltaire pour la Liberte'
d'Expression, Paris, France.
